[#item_full_content] A coalition of anti-marijuana groups and a cannabis-focused biopharmaceutical corporation have filed a new brief in their lawsuit challenging the Trump administration’s initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. In May, Judge Trevor N. McFadden dismissed the challenge to the Centers for Medicare & Medicaid Services 
Read More
Marijuana Opponents And Pharma Company File Brief Asking Court To Block Trump’s Hemp CBD Medicare Coverage Plan
ByPot Shop News
October 6, 2026